379 related articles for article (PubMed ID: 16006130)
21. Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives.
Brzozowski Z; Sławiński J; Gdaniec M; Innocenti A; Supuran CT
Eur J Med Chem; 2011 Sep; 46(9):4403-10. PubMed ID: 21820216
[TBL] [Abstract][Full Text] [Related]
22. Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides.
Vullo D; Franchi M; Gallori E; Antel J; Scozzafava A; Supuran CT
J Med Chem; 2004 Feb; 47(5):1272-9. PubMed ID: 14971907
[TBL] [Abstract][Full Text] [Related]
23. Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides.
Innocenti A; Firnges MA; Antel J; Wurl M; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):1149-54. PubMed ID: 15686931
[TBL] [Abstract][Full Text] [Related]
24. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?
Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G; Supuran CT
J Med Chem; 1999 Jul; 42(14):2641-50. PubMed ID: 10411484
[TBL] [Abstract][Full Text] [Related]
25. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides.
Güzel O; Innocenti A; Scozzafava A; Salman A; Parkkila S; Hilvo M; Supuran CT
Bioorg Med Chem; 2008 Oct; 16(20):9113-20. PubMed ID: 18819811
[TBL] [Abstract][Full Text] [Related]
26. Carbonic anhydrase inhibitors. Interaction of 2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
Temperini C; Cecchi A; Boyle NA; Scozzafava A; Cabeza JE; Wentworth P; Blackburn GM; Supuran CT
Bioorg Med Chem Lett; 2008 Feb; 18(3):999-1005. PubMed ID: 18162396
[TBL] [Abstract][Full Text] [Related]
27. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.
Vullo D; Franchi M; Gallori E; Pastorek J; Scozzafava A; Pastorekova S; Supuran CT
Bioorg Med Chem Lett; 2003 Mar; 13(6):1005-9. PubMed ID: 12643899
[TBL] [Abstract][Full Text] [Related]
28. Carbonic anhydrase inhibitors. Regioselective synthesis of novel series 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.
Brzozowski Z; Sławiński J; Vullo D; Supuran CT
Eur J Med Chem; 2012 Oct; 56():282-91. PubMed ID: 22910138
[TBL] [Abstract][Full Text] [Related]
29. Carbonic anhydrase inhibitors: Selective inhibition of the extracellular, tumor-associated isoforms IX and XII over isozymes I and II with glycosyl-thioureido-sulfonamides.
Smaine FZ; Winum JY; Montero JL; Regainia Z; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2007 Sep; 17(18):5096-100. PubMed ID: 17646100
[TBL] [Abstract][Full Text] [Related]
30. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
[TBL] [Abstract][Full Text] [Related]
31. Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties.
Santos MA; Marques S; Vullo D; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2007 Mar; 17(6):1538-43. PubMed ID: 17251018
[TBL] [Abstract][Full Text] [Related]
32. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
Cecchi A; Winum JY; Innocenti A; Vullo D; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Dec; 14(23):5775-80. PubMed ID: 15501039
[TBL] [Abstract][Full Text] [Related]
33. Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides.
Nishimori I; Minakuchi T; Onishi S; Vullo D; Cecchi A; Scozzafava A; Supuran CT
Bioorg Med Chem; 2007 Dec; 15(23):7229-36. PubMed ID: 17826101
[TBL] [Abstract][Full Text] [Related]
34. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
[TBL] [Abstract][Full Text] [Related]
35. Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties.
Chazalette C; Masereel B; Rolin S; Thiry A; Scozzafava A; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2004 Dec; 14(23):5781-6. PubMed ID: 15501040
[TBL] [Abstract][Full Text] [Related]
36. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
Nishimori I; Minakuchi T; Morimoto K; Sano S; Onishi S; Takeuchi H; Vullo D; Scozzafava A; Supuran CT
J Med Chem; 2006 Mar; 49(6):2117-26. PubMed ID: 16539401
[TBL] [Abstract][Full Text] [Related]
37. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design.
Lehtonen JM; Parkkila S; Vullo D; Casini A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Jul; 14(14):3757-62. PubMed ID: 15203157
[TBL] [Abstract][Full Text] [Related]
38. Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.
Nishimori I; Vullo D; Innocenti A; Scozzafava A; Mastrolorenzo A; Supuran CT
J Med Chem; 2005 Dec; 48(24):7860-6. PubMed ID: 16302824
[TBL] [Abstract][Full Text] [Related]
39. Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides.
Cecchi A; Taylor SD; Liu Y; Hill B; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Dec; 15(23):5192-6. PubMed ID: 16203142
[TBL] [Abstract][Full Text] [Related]
40. Carbonic anhydrase inhibitors: purification and inhibition studies of pigeon (Columba livia var. domestica) red blood cell carbonic anhydrase with sulfonamides.
Ozensoy O; Arslan M; Supuran CT
J Enzyme Inhib Med Chem; 2011 Oct; 26(5):749-53. PubMed ID: 21476925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
